Clinical Trial

Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor Exosomes

Study acronym: ExoGLIE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 13, 2024 (before its estimated May 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this pilot study is that exosomes constitute a more interesting support for analyzes allowing a broader screening of molecular alterations to be carried out with more reliable, more sensitive and more efficient results than the reference Foundation One Liquid CDx test.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-31.
Status change: Not Yet Recruiting → Recruiting 2024-12-10
Trial Details
NCT Number NCT06116903
Lead Sponsor University Hospital, Limoges
Conditions Glioma
Enrollment 60 participants
Start Date 2024-04-11
Primary Completion 2025-05-15 (estimated)
Study Completion 2025-12-15 (estimated)
Updated on ClinicalTrials.gov 2024-12-13